Atrial arrhythmias in Takotsubo cardiomyopathy: incidence, predictive factors, and prognosis.
Aged
Aged, 80 and over
Atrial Fibrillation
/ diagnosis
Atrial Flutter
/ diagnosis
Biomarkers
/ blood
C-Reactive Protein
/ metabolism
Female
France
/ epidemiology
Hospital Mortality
Humans
Incidence
Male
Middle Aged
Natriuretic Peptide, Brain
/ blood
Prognosis
Retrospective Studies
Risk Assessment
Risk Factors
Stroke Volume
Takotsubo Cardiomyopathy
/ diagnosis
Time Factors
Troponin
/ blood
Ventricular Function, Left
Journal
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
ISSN: 1532-2092
Titre abrégé: Europace
Pays: England
ID NLM: 100883649
Informations de publication
Date de publication:
01 Feb 2019
01 Feb 2019
Historique:
received:
16
02
2018
accepted:
09
06
2018
pubmed:
15
7
2018
medline:
8
9
2020
entrez:
15
7
2018
Statut:
ppublish
Résumé
Takotsubo cardiomyopathy (TTC) is a stress-related transient cardiomyopathy. It is unclear whether TTC is associated with poorer prognosis when atrial arrhythmia (AA), atrial fibrillation or flutter, occurs. The purpose of this study was to assess the incidence of AA in patients with TTC, predictive factors of AA, and its association with mortality. We studied 214 consecutive cases of TTC over 8 years. The study cohort was divided into two groups-those with newly diagnosed AA (AA-group) and those without (non-AA group). AA occurred in 24.8% of the patients. The AA group presented with lower left ventricular ejection fraction (LVEF) on admission and higher cardiac arrest rate. Admission and peak levels of troponin, B-type natriuretic peptide (BNP), C-reactive protein (CRP), and leucocytes were higher in the AA group. In-hospital, 30-day, cardiovascular, and all-cause mortality were significantly higher in the AA group. Independent predictors of newly diagnosed AA were troponin peak [odds ratio (OR) 1.03 (1.003-1.06); P = 0.029], CRP peak [OR 1.006 (1.001-1.01); P = 0.026], and LVEF on admission [OR 0.96 (0.93-0.99); P = 0.01]. Newly diagnosed AA was not predictive of mortality. The BNP peak [OR 1.00 (1.000-1.001); P = 0.022] and leucocytes peak [OR 1.095 (1.034-1.16); P = 0.002] were predictive factors of in-hospital mortality. LVEF upon discharge [OR 0.935 (0.899-0.972); P = 0.001] and leucocytes peak [OR 1.068 (1.000-1.139); P = 0.049] were predictive of cardiovascular death. Newly diagnosed AA is frequently observed in patients presenting with TTC and is associated with poorer short- and long-term prognosis. Inflammation, myocardial damage, and LVEF are predictors of AA onset and cardiovascular mortality.
Identifiants
pubmed: 30007327
pii: 5051707
doi: 10.1093/europace/euy147
doi:
Substances chimiques
Biomarkers
0
Troponin
0
Natriuretic Peptide, Brain
114471-18-0
C-Reactive Protein
9007-41-4
Types de publication
Comparative Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
298-305Commentaires et corrections
Type : CommentIn